BioCare Introduces Quality and Regulatory Consultancy Service
QRCare aims to help manufacturing partners in a variety of compliance and regulatory needs
Specialty therapy distributor BioCare has announced the launch of QRCare, a quality and regulatory consultancy service that provides BioCare‘s partners with the support needed to develop and maintain strategic quality and regulatory efforts.
QRCare offers assistance to customers throughout their quality and regulatory journeys, whether they are establishing a system from the ground up, preparing for a supply chain inspection or implementing change control, the company reports.
QRCare is led by industry experts Kathleen Hopping, vice president of regulatory affairs, and Peggy Yena, vice president of quality. “The patient experience drives everything we do,” said Hopping. “By offering much-needed assistance to specialty drug manufacturers and partners, we are ultimately enabling critically needed and potentially life-saving medications to be available to patient populations sooner.”
“Our goal is to be the most trusted quality and regulatory experts for our partners,” added Yena.
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
New UK Consortium Obtains $1.34M Grant to Launch Automated Cell Therapy Manufacturing Platform
July 15th 2025Cellular Origins, CGT Catapult, and Resolution Therapeutics partner up to design a fully automated, scalable CGT manufacturing solution, with the goal of accelerating patient access to cell therapies.
Study Connects COVID-19 Treatment Disparities to Gaps in Testing and Virtual Access
July 11th 2025New research finds that nearly half of the racial and ethnic disparities in outpatient COVID-19 antiviral prescriptions stem from encounter-level care barriers, such as limited access to rapid tests and telehealth, which emphasizes the need for systemic and practice-level reforms.
